Cost-effectiveness of losartan in patients with hypertension and LVH in Spain: An economic evaluation based on the life trial

被引:1
|
作者
Ruilope, LM
Burke, TA
Carides, GW
Nocea, G
机构
[1] Hosp 12 Octubre, E-28041 Madrid, Spain
[2] Merck & Co Inc, Whitehouse Stn, NJ USA
[3] Merck Res Labs, Blue Bell, PA USA
[4] MSD Spain, Madrid, Spain
关键词
D O I
10.1016/S1098-3015(10)65797-X
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:689 / 689
页数:1
相关论文
共 50 条
  • [31] THE COST-EFFECTIVENESS OF TREATING HYPERTENSION IN ELDERLY PEOPLE - AN ANALYSIS OF THE SWEDISH TRIAL IN OLD PATIENTS WITH HYPERTENSION (STOP HYPERTENSION)
    JOHANNESSON, M
    DAHLOF, B
    LINDHOLM, LH
    EKBOM, T
    HANSSON, L
    ODEN, A
    SCHERSTEN, B
    WESTER, PO
    JONSSON, B
    JOURNAL OF INTERNAL MEDICINE, 1993, 234 (03) : 317 - 323
  • [32] The cost-effectiveness and cost-consequences of a school-based social worker intervention: A within-trial economic evaluation
    Schroeder, Elizabeth-Ann
    Westlake, David
    Daher, Shahd
    Adara, Linda
    Ayayo, Sharon
    Bennett, Verity
    Kim, Sungwook
    Lugg-Widger, Fiona
    Meindl, Melissa
    Meister, Lena
    Munnery, Kim
    Pallmann, Philip
    Roberts, Louisa
    Rawlinson, Sarah
    White, James
    Petrou, Stavros
    CHILDREN AND YOUTH SERVICES REVIEW, 2024, 166
  • [33] Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Spain
    Rodriguez-Leor, Oriol
    Ryschon, Anne M.
    Cao, Khoa N.
    Jaen-Aguila, Fernando
    Garcia-Camarero, Tamara
    Mansilla-Morales, Carlos
    Kolovetsios, Michael
    Alvarez-Orozco, Maria
    Garcia-Donaire, Jose Antonio
    Pietzsch, Jan B.
    REC-INTERVENTIONAL CARDIOLOGY, 2024, 6 (04):
  • [34] InnovaSEC in Action: Cost-effectiveness of Barostim in the Treatment of Refractory Hypertension in Spain
    Soto, Marcelo
    Sampietro-Colom, Laura
    Sagarra, Joan
    Brugada-Terradellas, Josep
    REVISTA ESPANOLA DE CARDIOLOGIA, 2016, 69 (06): : 563 - 571
  • [35] Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Spain
    Rodriguez-Leor, Oriol
    Ryschon, Anne M.
    Cao, Khoa N.
    Jaen-Aguila, Fernando
    Garcia-Camarero, Tamara
    Mansilla-Morales, Carlos
    Kolovetsios, Michael
    Alvarez-Orozco, Maria
    Garcia-Donaire, Jose Antonio
    Pietzsch, Jan B.
    REC-INTERVENTIONAL CARDIOLOGY, 2024,
  • [36] The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM Trial
    Ogwulu, C. B. Okeke
    Goranitis, I
    Devall, A. J.
    Cheed, V
    Gallos, I. D.
    Middleton, L. J.
    Harb, H. M.
    Williams, H. M.
    Eapen, A.
    Daniels, J. P.
    Ahmed, A.
    Bender-Atik, R.
    Bhatia, K.
    Bottomley, C.
    Brewin, J.
    Choudhary, M.
    Deb, S.
    Duncan, W. C.
    Ewer, A. K.
    Hinshaw, K.
    Holland, T.
    Izzat, F.
    Johns, J.
    Lumsden, M.
    Manda, P.
    Norman, J. E.
    Nunes, N.
    Overton, C. E.
    Kriedt, K.
    Quenby, S.
    Rao, S.
    Ross, J.
    Shahid, A.
    Underwood, M.
    Vaithilingham, N.
    Watkins, L.
    Wykes, C.
    Horne, A. W.
    Jurkovic, D.
    Coomarasamy, A.
    Roberts, T. E.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (06) : 757 - 767
  • [37] Cost-effectiveness of salmeterol in patients with chronic obstructive pulmonary disease: an economic evaluation
    Jones, PW
    Wilson, K
    Sondhi, S
    RESPIRATORY MEDICINE, 2003, 97 (01) : 20 - 26
  • [38] Losartan-based versus atenolol-based therapy in patients with hypertension and left ventricular hypertrophy: An economic evaluation of the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study for Germany
    Krobot, K. J.
    Carides, G. W.
    Wagner, A.
    Burke, T. A.
    VALUE IN HEALTH, 2006, 9 (06) : A353 - A353
  • [39] Cost-effectiveness evaluation of the PROPPR trial transfusion protocols
    Callcut, Rachael A.
    Simpson, Kit N.
    Baraniuk, Sarah
    Fox, Erin E.
    Tilley, Barbara C.
    Holcomb, John B.
    TRANSFUSION, 2020, 60 (05) : 922 - 931
  • [40] Cost-effectiveness evaluation to inform clinical trial design
    Ribaudo, Heather J.
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (08) : 1071 - 1073